{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:37:25Z","timestamp":1784173045660,"version":"3.55.0"},"reference-count":40,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":732,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1002\/pbc.24722","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T09:59:37Z","timestamp":1377856777000},"page":"2018-2024","source":"Crossref","is-referenced-by-count":40,"title":["Ten-year follow-up of pediatric patients with non-hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation"],"prefix":"10.1002","volume":"60","author":[{"given":"Lisa","family":"Giulino-Roth","sequence":"first","affiliation":[{"name":"Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York New York"},{"name":"Department of Pediatrics; Weill Cornell Medical College; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Ricafort","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Albert Einstein College of Medicine; Bronx New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Kernan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudy N.","family":"Small","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York New York"},{"name":"Department of Pediatrics; Weill Cornell Medical College; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Trippett","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Steinherz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York New York"},{"name":"Department of Pediatrics; Weill Cornell Medical College; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Prockop","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Scaradavou","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"O'Reilly","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York New York"},{"name":"Department of Pediatrics; Weill Cornell Medical College; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Boulad","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York New York"},{"name":"Department of Pediatrics; Weill Cornell Medical College; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"10.1002\/pbc.24722-BIB0001|pbc24722-cit-0001","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/1097-0142(197407)34:1<204::AID-CNCR2820340131>3.0.CO;2-2","article-title":"Non-Hodgkin's lymphomas. VI. Results of treatment in childhood","volume":"34","author":"Glatstein","year":"1974","journal-title":"Cancer"},{"key":"10.1002\/pbc.24722-BIB0002|pbc24722-cit-0002","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/cncr.2820360928","article-title":"A study of childhood non-Hodgkin's lymphoma","volume":"36","author":"Murphy","year":"1975","journal-title":"Cancer"},{"key":"10.1002\/pbc.24722-BIB0003|pbc24722-cit-0003","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/jnci\/djn276","article-title":"Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004","volume":"100","author":"Pulte","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/pbc.24722-BIB0004|pbc24722-cit-0004","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"10.1002\/pbc.24722-BIB0005|pbc24722-cit-0005","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: A report of the BFM Group Study NHL-BFM95","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"key":"10.1002\/pbc.24722-BIB0006|pbc24722-cit-0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1002\/pbc.24722-BIB0007|pbc24722-cit-0007","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM199710303371802","article-title":"Treatment of children and young adults with early-stage non-Hodgkin's lymphoma","volume":"337","author":"Link","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24722-BIB0008|pbc24722-cit-0008","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2141.2008.07144.x","article-title":"Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: Results of the FAB\/LMB 96 international study","volume":"141","author":"Gerrard","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1002\/pbc.24722-BIB0009|pbc24722-cit-0009","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"key":"10.1002\/pbc.24722-BIB0010|pbc24722-cit-0010","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: It is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"key":"10.1002\/pbc.24722-BIB0011|pbc24722-cit-0011","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/pbc.21817","article-title":"Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of Children's Cancer Group Study 594","volume":"52","author":"Lowe","year":"2009","journal-title":"Pediatric Blood Cancer"},{"key":"10.1002\/pbc.24722-BIB0012|pbc24722-cit-0012","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2008.18.1487","article-title":"Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: Results of a randomized trial of the EICNHL Group","volume":"27","author":"Brugieres","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.24722-BIB0013|pbc24722-cit-0013","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.2010.28.5999","article-title":"Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: Results of the randomized ALCL99-vinblastine trial","volume":"28","author":"Le Deley","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.24722-BIB0014|pbc24722-cit-0014","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: A BFM group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"key":"10.1002\/pbc.24722-BIB0015|pbc24722-cit-0015","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1200\/JCO.2001.19.9.2390","article-title":"Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-591","volume":"19","author":"Kobrinsky","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.24722-BIB0016|pbc24722-cit-0016","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.bmt.1701002","article-title":"High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: A phase I\/II study","volume":"20","author":"Kleiner","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0017|pbc24722-cit-0017","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24722-BIB0018|pbc24722-cit-0018","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.bmt.1700904","article-title":"Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma","volume":"20","author":"Dann","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0019|pbc24722-cit-0019","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbmt.2009.08.011","article-title":"A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: A report from the CIBMTR","volume":"16","author":"Lazarus","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0020|pbc24722-cit-0020","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2002-05-1483","article-title":"A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma","volume":"101","author":"Levine","year":"2003","journal-title":"Blood"},{"key":"10.1002\/pbc.24722-BIB0021|pbc24722-cit-0021","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","article-title":"An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: Allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation","volume":"31","author":"Peniket","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0022|pbc24722-cit-0022","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1702625","article-title":"Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): Results of a provincial strategy. Ontario BMT Network, Canada","volume":"26","author":"Schimmer","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0023|pbc24722-cit-0023","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbmt.2009.09.021","article-title":"Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents","volume":"16","author":"Gross","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0024|pbc24722-cit-0024","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1097\/MPH.0b013e3181fd6c79","article-title":"High-dose busulfan and cyclophosphamide as a conditioning regimen for autologous peripheral blood stem cell transplantation in childhood non-Hodgkin lymphoma patients: A long-term follow-up study","volume":"33","author":"Andion","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1002\/pbc.24722-BIB0025|pbc24722-cit-0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1008352726155","article-title":"Relapses of childhood anaplastic large-cell lymphoma: Treatment results in a series of 41 children-A report from the French Society of Pediatric Oncology","volume":"11","author":"Brugieres","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1002\/pbc.24722-BIB0026|pbc24722-cit-0026","first-page":"353","article-title":"Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children","volume":"15","author":"Bureo","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0027|pbc24722-cit-0027","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbmt.2010.07.002","article-title":"Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: Results of Children's Oncology Group study A 596","volume":"17","author":"Harris","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0028|pbc24722-cit-0028","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/146532402320219763","article-title":"Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL","volume":"4","author":"Sandlund","year":"2002","journal-title":"Cytotherapy"},{"key":"10.1002\/pbc.24722-BIB0029|pbc24722-cit-0029","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.2011.34.8417","article-title":"Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: A BFM-group study","volume":"29","author":"Woessmann","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.24722-BIB0030|pbc24722-cit-0030","volume-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1002\/pbc.24722-BIB0031|pbc24722-cit-0031","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0032|pbc24722-cit-0032","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1002\/pbc.24722-BIB0033|pbc24722-cit-0033","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1002\/pbc.24722-BIB0034|pbc24722-cit-0034","first-page":"129","article-title":"Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow","volume":"10","author":"Gulati","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0035|pbc24722-cit-0035","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","article-title":"Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: A case-controlled analysis of the European Bone Marrow Transplant Group Registry data","volume":"10","author":"Chopra","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.24722-BIB0036|pbc24722-cit-0036","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood.V90.8.2921","article-title":"High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: A report from the European Lymphoma Bone Marrow Transplantation Registry","volume":"90","author":"Ladenstein","year":"1997","journal-title":"Blood"},{"key":"10.1002\/pbc.24722-BIB0037|pbc24722-cit-0037","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1701596","article-title":"Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: Analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT)","volume":"23","author":"Fanin","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0038|pbc24722-cit-0038","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2006.06004.x","article-title":"Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents-A Berlin-Frankfurt-Munster group report","volume":"133","author":"Woessmann","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1002\/pbc.24722-BIB0039|pbc24722-cit-0039","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bbmt.2011.01.005","article-title":"T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies","volume":"17","author":"Jakubowski","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/pbc.24722-BIB0040|pbc24722-cit-0040","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/bmt.2009.371","article-title":"Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT","volume":"45","author":"Perales","year":"2010","journal-title":"Bone Marrow Transplant"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24722","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24722","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.24722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T21:19:03Z","timestamp":1596403143000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pbc.24722"}},"subtitle":["Allo- and Auto-SCT for Pediatric NHL"],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.24722","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}